Free Trial
OTCMKTS:PBSV

Pharma-Bio Serv (PBSV) Stock Price, News & Analysis

Pharma-Bio Serv logo
$0.60 0.00 (0.00%)
As of 07/8/2025 10:46 AM Eastern

About Pharma-Bio Serv Stock (OTCMKTS:PBSV)

Key Stats

Today's Range
$0.60
$0.60
50-Day Range
$0.43
$0.60
52-Week Range
$0.31
$0.67
Volume
21,903 shs
Average Volume
6,375 shs
Market Capitalization
$13.76 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PBSV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pharma-Bio Serv and its competitors with MarketBeat's FREE daily newsletter.

PBSV Stock News Headlines

PBSV Pharma-Bio Serv, Inc. - Seeking Alpha
Trump’s Exec Order #14154 could be a “Millionaire-Maker”
Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.” We recently sat down with Rickards to capture all the key details on tape.
PBSV Decisions Paying Off
PBSV Returns to Growth
PBSV Released Earnings and Declares Dividend
See More Headlines

PBSV Stock Analysis - Frequently Asked Questions

Pharma-Bio Serv's stock was trading at $0.5499 at the start of the year. Since then, PBSV stock has increased by 9.1% and is now trading at $0.60.

Pharma-Bio Serv Inc. (OTCMKTS:PBSV) released its earnings results on Monday, March, 17th. The company reported $0.37 earnings per share for the quarter, topping the consensus estimate of $0.02 by $0.35. The business had revenue of $2.47 million for the quarter, compared to analysts' expectations of $2.70 million. Pharma-Bio Serv had a negative net margin of 1.96% and a negative trailing twelve-month return on equity of 1.47%.

Shares of PBSV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Pharma-Bio Serv investors own include AT&T (T), Annaly Capital Management (NLY), BlackRock Multi-Sector Income Trust (BIT), GE Aerospace (GE), Exxon Mobil (XOM), Enterprise Products Partners (EPD) and First BanCorp. (FBP).

Company Calendar

Last Earnings
3/17/2025
Today
7/08/2025
Next Earnings (Estimated)
9/15/2025
Fiscal Year End
10/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Consulting
Sub-Industry
Business Services
Current Symbol
OTCMKTS:PBSV
CIK
1304161
Employees
185
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
5.45
P/E Growth
N/A
Net Income
-$780 thousand
Pretax Margin
-2.01%

Debt

Sales & Book Value

Annual Sales
$9.51 million
Price / Cash Flow
N/A
Book Value
$0.60 per share
Price / Book
1.00

Miscellaneous

Free Float
20,043,000
Market Cap
$13.76 million
Optionable
Not Optionable
Beta
0.68

Social Links

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

This page (OTCMKTS:PBSV) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners